July 2019 Cancer Epidemiology Matters E-News

Cancer Epidemiology Matters E-News

July 2019

NIH Expands Use of Notices of Special Interest (NOSI)

What is a NOSI?

A NOSI represents a major change in how we communicate our research priorities to the research community. A NOSI is a standard, formal format for NIH institutes to share and update their research priorities. Each NOSI describes aims in a specific scientific area and points to a funding opportunity announcement through which investigators can apply for support.

A NOSI is a special announcement used to fill scientific gaps. Other standard announcements include requests for applications (RFAs) and program announcements with special receipt or review (PARs).

How Does a NOSI Work?

A NOSI will describe specific topics of interest, for example a specific area of research, and will direct applicants to one or more active funding opportunity announcements (FOAs), often a parent announcement, for submission of applications for the initiative described.

A NOSI is not an FOA and is listed as a notice in the NIH Guide for Grants and Contracts. An example of a NOSI published in July 2019 is NOT-RM-19-009, which announced the availability of administrative supplements for enhancing utility and usage of Common Fund data sets.

Applicants should read NOSIs carefully for any special requirements related to that specific announcement. See NOT-OD-19-107 for additional information  about NOSIs and contact information to direct general questions about NOSIs.

Most NOSIs require applicants to include the notice number in the Agency Routing Identifier field (4b) of the SF424 (R&R) form so NIH can assign and track applications and awards for the described initiative. It is critical that applicants adhere to this notice instruction. The notice number must be included in the Agency Routing Identifier field (field 4b on the SF424 R&R form) at the time of application submission.

Investigators considering a grant application that falls within the scientific areas of interest of the Epidemiology and Genomics Research Program (EGRP) are welcome to contact EGRP’s scientific program directors to discuss how research ideas fit within the strategic priorities of EGRP, the Division of Cancer Control and Population Sciences, and NCI.

Funding Opportunities

  • Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)
  • Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
  • Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
  • Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
  • NCI Small Business Innovation Research Program Solicitation (PHS 2020-1)

Grants Policy Notices

Request for Information

Return to Top